Multiple pathways of type 1 interferon production in lupus: the case for amlexanox.
Todd I, Thomas RE, Watt BD, Sutherland L, Afriyie-Asante A, Deb B, Joseph B, Tighe PJ, Lanyon P, Fairclough LC.
Todd I, et al. Among authors: fairclough lc.
Rheumatology (Oxford). 2020 Dec 1;59(12):3980-3982. doi: 10.1093/rheumatology/keaa469.
Rheumatology (Oxford). 2020.
PMID: 32888016
No abstract available.